PLEKHA5 and melanoma: Utilizing the Transwell chamber migration assay, we observed a significant reduction in the number of A2058 cells traversing the Transwell chamber following PLEKHA5 knockdown (Figure 4E), indicating that PLEKHA5 knockdown can inhibit the migration of melanoma cells A2058.